Search

Search Constraints

You searched for: Author/Creator Fields, Ryan

Search Results

1. Adjuvant therapy following resection of gastroenteropancreatic neuroendocrine tumors provides no recurrence or survival benefit. Issue 7 (9th March 2020)

2. Analysis of textbook outcomes among patients undergoing resection of retroperitoneal sarcoma: A multi‐institutional analysis of the US Sarcoma Collaborative. Issue 6 (21st July 2020)

3. Clinical relevance of performing endoscopic ultrasound‐guided fine‐needle biopsy for pancreatic neuroendocrine tumors less than 2 cm. Issue 7 (11th August 2020)

4. Clinicopathological features and prognosis of gastric cardia adenocarcinoma: A multi‐institutional U.S. study. Issue 3 (10th October 2014)

5. Duodenal neuroendocrine tumors: Impact of tumor size and total number of lymph nodes examined. Issue 8 (3rd November 2019)

6. Impact of tumor size and nodal status on recurrence of nonfunctional pancreatic neuroendocrine tumors ≤2 cm after curative resection: A multi‐institutional study of 392 cases. Issue 7 (30th September 2019)

7. Incidence and impact of Textbook Outcome among patients undergoing resection of pancreatic neuroendocrine tumors: Results of the US Neuroendocrine Tumor Study Group. Issue 8 (17th March 2020)

8. Indications and outcomes of enucleation versus formal pancreatectomy for pancreatic neuroendocrine tumors. Issue 3 (March 2021)

9. Jaundice: an important, poorly recognized risk factor for diminished survival in patients with adenocarcinoma of the head of the pancreas. Issue 2 (22nd April 2013)

10. Minimally invasive versus open distal pancreatectomy for pancreatic neuroendocrine tumors: An analysis from the U.S. neuroendocrine tumor study group. Issue 2 (18th April 2019)